Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines

Tara Sanft; Andrew Day; Lindsay Peterson; M. Alma Rodriguez; Shannon Ansbaugh; Saro Armenian; K. Scott Baker; Tarah Ballinger; Gregory Broderick; Wendy Demark-Wahnefried; Kristin Dickinson; Nathan Paul Fairman; Debra L. Friedman; Mindy Goldman; Norah Lynn Henry; Christine Hill-Kayser; Melissa Hudson; Nazanin Khakpour; Divya Koura; Allison L. McDonough; Michelle Melisko; Kathi Mooney; Halle C.F. Moore; Natalie Moryl; Heather Neuman; Tracey O’Connor; Linda Overholser; Electra D. Paskett; Chirayu Patel; William Pirl; Andrea Porpiglia; Kathryn J. Ruddy; Lidia Schapira; Lillie Shockney; Sophia Smith; Karen L. Syrjala; Amye Tevaarwerk; Eric H. Yang; Phyllis Zee; Nicole R. McMillian; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2022.0052

Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines

Tara Sanft, Andrew Day, Lindsay Peterson, M. Alma Rodriguez, Shannon Ansbaugh, Saro Armenian, K. Scott Baker, Tarah Ballinger, Gregory Broderick, Wendy Demark-Wahnefried, Kristin Dickinson, Nathan Paul Fairman, Debra L. Friedman, Mindy Goldman, Norah Lynn Henry, Christine Hill-Kayser, Melissa Hudson, Nazanin Khakpour, Divya Koura, Allison L. McDonoughMichelle Melisko, Kathi Mooney, Halle C.F. Moore, Natalie Moryl, Heather Neuman, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Chirayu Patel, William Pirl, Andrea Porpiglia, Kathryn J. Ruddy, Lidia Schapira, Lillie Shockney, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Eric H. Yang, Phyllis Zee, Nicole R. McMillian, Deborah A. Freedman-Cass

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.

Original language	English
Pages (from-to)	1080-1090
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	20
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2022.0052
State	Published - Oct 2022

Access to Document

10.6004/jnccn.2022.0052

Cite this

Sanft, T., Day, A., Peterson, L., Rodriguez, M. A., Ansbaugh, S., Armenian, S., Baker, K. S., Ballinger, T., Broderick, G., Demark-Wahnefried, W., Dickinson, K., Fairman, N. P., Friedman, D. L., Goldman, M., Henry, N. L., Hill-Kayser, C., Hudson, M., Khakpour, N., Koura, D., ... Freedman-Cass, D. A. (2022). Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 20(10), 1080-1090. https://doi.org/10.6004/jnccn.2022.0052

@article{f377ca6ce4cd4b5f835e4623acefff24,

title = "Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors{\textquoteright} complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.",

author = "Tara Sanft and Andrew Day and Lindsay Peterson and Rodriguez, {M. Alma} and Shannon Ansbaugh and Saro Armenian and Baker, {K. Scott} and Tarah Ballinger and Gregory Broderick and Wendy Demark-Wahnefried and Kristin Dickinson and Fairman, {Nathan Paul} and Friedman, {Debra L.} and Mindy Goldman and Henry, {Norah Lynn} and Christine Hill-Kayser and Melissa Hudson and Nazanin Khakpour and Divya Koura and McDonough, {Allison L.} and Michelle Melisko and Kathi Mooney and Moore, {Halle C.F.} and Natalie Moryl and Heather Neuman and Tracey O{\textquoteright}Connor and Linda Overholser and Paskett, {Electra D.} and Chirayu Patel and William Pirl and Andrea Porpiglia and Ruddy, {Kathryn J.} and Lidia Schapira and Lillie Shockney and Sophia Smith and Syrjala, {Karen L.} and Amye Tevaarwerk and Yang, {Eric H.} and Phyllis Zee and McMillian, {Nicole R.} and Freedman-Cass, {Deborah A.}",

note = "Funding Information: Eric H. Yang, MD, Panel Member, has disclosed receiving grant/research support from Boehringer Ingelheim GmbH, CSL Behring, and Eli Lilly and Company; and receiving consulting fees from Pfizer Inc. Phyllis Zee, MD, PhD, Panel Member, has disclosed serving as a scientific advisor for CVS Caremark, Idorsia Pharmaceuticals Ltd., Jazz Pharmaceuticals Inc., and sanofi-aventis U.S.; receiving consulting fees from CVS Caremark, Eisai Inc., Idorsia Pharmaceuticals Ltd., and Jazz Pharmaceuticals Inc.; receiving grant/research support from Vanda Pharmaceuticals Inc.; and owning equity interest/stock options in Teva Pharmaceuticals. Funding Information: This activity is supported by educational grants from AstraZeneca; BeiGene; Exact Sciences; Gilead Sciences, Inc.; GlaxoSmithKline; Lantheus Medical Imaging Inc.; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Taiho Oncology, Inc. This activity is supported by an independent educational grant from Astellas. This activity is supported by an education grant from Astellas and Seagen Inc. This activity is supported by a medical education grant from Karyopharm{\textregistered} Therapeutics. This activity is supported through an Independent Medical Education grant from Merck & Co., Inc. Publisher Copyright: {\textcopyright} JNCCN—Journal of the National Comprehensive Cancer Network.",

year = "2022",

month = oct,

doi = "10.6004/jnccn.2022.0052",

language = "English",

volume = "20",

pages = "1080--1090",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "10",

}

Sanft, T, Day, A, Peterson, L, Rodriguez, MA, Ansbaugh, S, Armenian, S, Baker, KS, Ballinger, T, Broderick, G, Demark-Wahnefried, W, Dickinson, K, Fairman, NP, Friedman, DL, Goldman, M, Henry, NL, Hill-Kayser, C, Hudson, M, Khakpour, N, Koura, D, McDonough, AL, Melisko, M, Mooney, K, Moore, HCF, Moryl, N, Neuman, H, O’Connor, T, Overholser, L, Paskett, ED, Patel, C, Pirl, W, Porpiglia, A, Ruddy, KJ, Schapira, L, Shockney, L, Smith, S, Syrjala, KL, Tevaarwerk, A, Yang, EH, Zee, P, McMillian, NR & Freedman-Cass, DA 2022, 'Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 20, no. 10, pp. 1080-1090. https://doi.org/10.6004/jnccn.2022.0052

TY - JOUR

T1 - Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines

AU - Sanft, Tara

AU - Day, Andrew

AU - Peterson, Lindsay

AU - Rodriguez, M. Alma

AU - Ansbaugh, Shannon

AU - Armenian, Saro

AU - Baker, K. Scott

AU - Ballinger, Tarah

AU - Broderick, Gregory

AU - Demark-Wahnefried, Wendy

AU - Dickinson, Kristin

AU - Fairman, Nathan Paul

AU - Friedman, Debra L.

AU - Goldman, Mindy

AU - Henry, Norah Lynn

AU - Hill-Kayser, Christine

AU - Hudson, Melissa

AU - Khakpour, Nazanin

AU - Koura, Divya

AU - McDonough, Allison L.

AU - Melisko, Michelle

AU - Mooney, Kathi

AU - Moore, Halle C.F.

AU - Moryl, Natalie

AU - Neuman, Heather

AU - O’Connor, Tracey

AU - Overholser, Linda

AU - Paskett, Electra D.

AU - Patel, Chirayu

AU - Pirl, William

AU - Porpiglia, Andrea

AU - Ruddy, Kathryn J.

AU - Schapira, Lidia

AU - Shockney, Lillie

AU - Smith, Sophia

AU - Syrjala, Karen L.

AU - Tevaarwerk, Amye

AU - Yang, Eric H.

AU - Zee, Phyllis

AU - McMillian, Nicole R.

AU - Freedman-Cass, Deborah A.

N1 - Funding Information: Eric H. Yang, MD, Panel Member, has disclosed receiving grant/research support from Boehringer Ingelheim GmbH, CSL Behring, and Eli Lilly and Company; and receiving consulting fees from Pfizer Inc. Phyllis Zee, MD, PhD, Panel Member, has disclosed serving as a scientific advisor for CVS Caremark, Idorsia Pharmaceuticals Ltd., Jazz Pharmaceuticals Inc., and sanofi-aventis U.S.; receiving consulting fees from CVS Caremark, Eisai Inc., Idorsia Pharmaceuticals Ltd., and Jazz Pharmaceuticals Inc.; receiving grant/research support from Vanda Pharmaceuticals Inc.; and owning equity interest/stock options in Teva Pharmaceuticals. Funding Information: This activity is supported by educational grants from AstraZeneca; BeiGene; Exact Sciences; Gilead Sciences, Inc.; GlaxoSmithKline; Lantheus Medical Imaging Inc.; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Taiho Oncology, Inc. This activity is supported by an independent educational grant from Astellas. This activity is supported by an education grant from Astellas and Seagen Inc. This activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported through an Independent Medical Education grant from Merck & Co., Inc. Publisher Copyright: © JNCCN—Journal of the National Comprehensive Cancer Network.

PY - 2022/10

Y1 - 2022/10

N2 - The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.

AB - The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors’ complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.

UR - http://www.scopus.com/inward/record.url?scp=85139885137&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2022.0052

DO - 10.6004/jnccn.2022.0052

M3 - Article

C2 - 36240847

AN - SCOPUS:85139885137

SN - 1540-1405

VL - 20

SP - 1080

EP - 1090

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Survivorship, Version 1.2022 Featured Updates to the NCCN Guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this